Results for this period
Third quarter1 July 2025 to 31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Solid organic growth at existing hospitals, contributions from existing and new Group companies, expansion of the business platform through M&A and business succession, greater operating efficiency and cost synergies from Group management, revisions to medical service prices, and the placement of personnel in the right positions
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 July 2025 to 31 March 2026 |
| Net Sales | ¥4,318 million (YoY +13.6%) |
| Operating profit | ¥674 million (YoY +43.6%) |
| Ordinary income | ¥687 million (YoY +34.7%) |
| Profit attributable to owners of the parent | ¥597 million (YoY +98.5%) |
| Net income per share | ¥79.58 |
| Equity ratio | End of the current fiscal period 51.8 / End of previous period 44.9 |
| Total assets | ¥6,473 million |
| Net assets | ¥3,364 million |
| Full-year earnings forecast | Net Sales ¥6,150 million (YoY +12.6%) / Operating profit ¥1,100 million (YoY +21.0%) / Ordinary income ¥1,100 million (YoY +21.1%) / Net income ¥840 million (YoY +41.6%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Depreciation and amortization | ¥149,000 thousand |
| Impairment loss | ¥0 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥7,700 thousand, Gain on negative goodwill ¥154,454 thousand, Gain on step acquisition ¥12,913 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥718 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 3 / Company name 飛鳥メディカル株式会社, 株式会社See, カルテック株式会社 / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者：Not disclosed) |
| Issued Shares at Period-End | 7,974,000 |
| Treasury Shares at Period-End | 424,100 |
| Factors Behind Changes in Business Performance | Solid organic growth at existing hospitals, contributions from existing and new Group companies, expansion of the business platform through M&A and business succession, greater operating efficiency and cost synergies from Group management, revisions to medical service prices, and the placement of personnel in the right positions |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to solid organic growth at existing hospitals and contributions from the performance of companies that joined the Group in the previous fiscal year and companies newly made subsidiaries. On the profit side, the effects of greater operating efficiency and cost synergies from Group management, revisions to medical service prices, and the placement of personnel in the right positions contributed despite temporary M&A-related expenses and higher personnel costs.